GR
Gregory Renza RBC Capital Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Cidara Therapeutics
CDTX
$1.6B
| $63.17 | $35 |
45%
downside
| Outperform | 3 months ago |
|
2
Acadia Pharmaceuticals
ACAD
$4.26B
| $25.26 | $26 |
3%
upside
| Outperform | 3 months ago |
|
3
ADC Therapeutics
ADCT
$398M
| $3.54 | $8 |
126%
upside
| Outperform | 3 months ago |
|
4
Exelixis
EXEL
$10.2B
| $37.88 | $40 |
6%
upside
| Outperform | 3 months ago |
|
|
ONC
5
BeOne Medicines Ltd. American Depositary Shares
ONC
$37.6B
| $341.80 | $311 |
9%
downside
| Outperform | 4 months ago |
|
6
Jazz Pharmaceuticals
JAZZ
$7.86B
| $129.50 | $172 |
33%
upside
| Outperform | 4 months ago |
|
|
BCYC
7
Bicycle Therapeutics
BCYC
$483M
| $7.16 | $32 |
347%
upside
| Outperform | 4 months ago |
|
8
Amgen
AMGN
$153B
| $283.64 | $320 |
13%
upside
| Outperform | 4 months ago |
|
9
CG Oncology
CGON
$2.52B
| $33.07 | $68 |
106%
upside
| Outperform | 4 months ago |
|
10
Perspective Therapeutics
CATX
$257M
| $3.46 | $15 |
334%
upside
| Outperform | 5 months ago |
|
11
CorMedix
CRMD
$926M
| $12.40 | $12 |
3%
downside
| Outperform | 5 months ago |
|
12
Verastem
VSTM
$663M
| $10.77 | $14 |
30%
upside
| Outperform | 5 months ago |
|
13
Xencor
XNCR
$610M
| $8.55 | $32 |
274%
upside
| Outperform | 6 months ago |
|
14
Nurix Therapeutics
NRIX
$758M
| $9.91 | $27 |
172%
upside
| Outperform | 7 months ago |
|
15
IDEAYA Biosciences
IDYA
$2.38B
| $27.16 | $61 |
125%
upside
| Outperform | 7 months ago |
|
16
Pacira BioSciences
PCRX
$1.19B
| $26.45 | $18 |
32%
downside
| Sector Perform | 7 months ago |
|
17
Nuvation Bio
NUVB
$1.33B
| $3.90 | $10 |
156%
upside
| Outperform | 8 months ago |
|
18
MannKind Corp
MNKD
$1.7B
| $5.54 | $10 |
81%
upside
| Outperform | 8 months ago |
|
19
Viridian Therapeutics
VRDN
$1.53B
| $18.72 | $47 |
151%
upside
| Outperform | 8 months ago |
|
20
Agios Pharmaceuticals
AGIO
$2.09B
| $36.01 | $57 |
58%
upside
| Outperform | 9 months ago |
|
21
Fulcrum Therapeutics
FULC
$414M
| $7.66 | $4 |
48%
downside
| Sector Perform | 9 months ago |
|
|
ATYR
22
aTyr Pharma
ATYR
$550M
| $5.61 | $16 |
185%
upside
| Outperform | 1 year ago |
|